within Pharmacolibrary.Drugs.ATC.H;

model H01BA03
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.05,
    Cl             = 0.16666666666666666,
    adminDuration  = 600,
    adminMass      = 0.01,
    adminCount     = 1,
    Vd             = 0.0002,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0,
    Tlag           = 0
  );

  annotation(Documentation(
    info ="<html><body><p>Lypressin (lysine vasopressin) is a synthetic analogue of the natural antidiuretic hormone vasopressin, previously used to treat diabetes insipidus, particularly central diabetes insipidus. It acts as a replacement for ADH deficiency by promoting water reabsorption in the renal collecting ducts. Lypressin is no longer widely used, having been replaced by desmopressin for this indication.</p><h4>Pharmacokinetics</h4><p>No peer-reviewed clinical pharmacokinetic studies specifically reporting parameters for lypressin in humans could be identified. The following are estimated pharmacokinetic values based on general vasopressin analogues and known properties.</p><h4>References</h4><ol><li><p>Baena-Cagnani, CE (2004). Safety and tolerability of treatments for allergic rhinitis in children. <i>Drug safety</i> 27(12) 883–898. DOI:<a href=&quot;https://doi.org/10.2165/00002018-200427120-00005&quot;>10.2165/00002018-200427120-00005</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/15366976/&quot;>https://pubmed.ncbi.nlm.nih.gov/15366976</a></p></li><li><p>Akerlund, M, et al., &amp; Trojnar, J (1986). Vasotocin analogues which competitively inhibit vasopressin stimulated uterine activity in healthy women. <i>British journal of obstetrics and gynaecology</i> 93(1) 22–27. DOI:<a href=&quot;https://doi.org/10.1111/j.1471-0528.1986.tb07807.x&quot;>10.1111/j.1471-0528.1986.tb07807.x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/3942702/&quot;>https://pubmed.ncbi.nlm.nih.gov/3942702</a></p></li><li><p>Radó, JP, et al., &amp; Fischer, J (1976). The antidiuretic action of 1-deamino-8-D-arginine vasopressin (DDAVP) in man. <i>International journal of clinical pharmacology and biopharmacy</i> 13(3) 199–209. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/950263/&quot;>https://pubmed.ncbi.nlm.nih.gov/950263</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end H01BA03;
